SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
研友_Z6W9B8
Lv1
20 积分
2020-07-12 加入
最近求助
最近应助
互助留言
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial
9天前
已完结
KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation
9天前
已完结
Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now
9天前
已完结
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies
12天前
已完结
Defining tumor resistance to PD-1 pathway blockade: recommendations from the first meeting of the SITC Immunotherapy Resistance Taskforce
13天前
已完结
没有进行任何应助
感谢,速度真快
12天前
感谢
12天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论